Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Opdualag × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 8 Recurrence 1 Patient Preference 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Lymphoma 1 Central Nervous System Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1

Interventions

pembrolizumab 2 relatlimab 1 lifileucel 1 Temozolomide 1 Paclitaxel 1 Opdualag 1 Nivolumab 1 Ipilimumab 1 Electrochemotherapy 1 Dacarbazine 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06743126 2026-04-21

SUPRAME

Immatics US, Inc.

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡